Positron emission tomography for brain research.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi

• Publication date

  2008-04-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1272/JNMS.75.68PMID 18475026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy

  2008cited by this paper
• [11C]Flumazenil PET in Temporal Lobe Epilepsy: Do We Need an Arterial Input Function or Kinetic Modeling?

  2008cited by this paper
• Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy

  2008cited by this paper
• Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification

  2008cited by this paper
• Robust estimation of the arterial input function for Logan plots using an intersectional searching algorithm and clustering in positron emission tomography for neuroreceptor imaging

  2008cited by this paper
• Low density of sigma1 receptors in early Alzheimer’s disease

  2008cited by this paper
• Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping

  2008cited by this paper
• Imaging β-amyloid burden in aging and dementia

  2007cited by this paper
• Correlation between each task of the Mini‐Mental State Examination and regional glucose hypometabolism in at‐rest Alzheimer's disease patients

  2007cited by this paper
• Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET

  2007cited by this paper
• 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients

  2007cited by this paper
• igh Occupancy of Sigma-1 Receptors in the Human rain after Single Oral Administration of Fluvoxamine : Positron Emission Tomography Study Using 11 C ] SA 4503

  2007cited by this paper
• Quantification of adenosine A2A receptors in the human brain using [11C]TMSX and positron emission tomography

  2007cited by this paper
• PET Tracers for Mapping Adenosine Receptors as Probes for Diagnosis of CNS Disorders

  2007cited by this paper
• Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.

  2007cited by this paper
• Distribution volume as an alternative to the binding potential for sigma1 receptor imaging

  2007cited by this paper
• High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.

  2007cited by this paper
• Glucose hypermetabolism in the thalamus of patients with essential blepharospasm

  2007cited by this paper
• Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503

  2007cited by this paper
• Quantitative Evaluation of Cerebral Hemodynamics in Patients with Moyamoya Disease by Dynamic Susceptibility Contrast Magnetic Resonance Imaging—Comparison with Positron Emission Tomography

  2006cited by this paper
• In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.

  2006cited by this paper
• Quantification of adenosine A 2 A receptors in the human brain using [ 11 C ] TMSX and positron emission tomography

  2006cited by this paper
• Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum.

  2006cited by this paper
• In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy

  2006cited by this paper
• A feasibility study of [11C]SA4503-PET for evaluating sigma1 receptor occupancy by neuroleptics: The binding of haloperidol to sigma1 and dopamine D2-like receptors

  2006cited by this paper
• Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.

  2006cited by this paper
• PET tracers for imaging of the dopaminergic system.

  2006cited by this paper
• Adenosine A1 receptor mapping of the human brain by PET with 8-dicyclopropylmethyl-1-11C-methyl-3-propylxanthine.

  2005cited by this paper
• Comparative overview of brain perfusion imaging techniques.

  2005cited by this paper
• Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis

  2005cited by this paper
• Adenosine A 1 Receptor Mapping of the Human

  2005cited by this paper
• Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study

  2005cited by this paper
• Function of sigma1 receptors in Parkinson's disease

  2005cited by this paper
• Regional changes in [ 18 F]dopa metabolism in the striatum in Parkinson's disease

  2005cited by this paper
• Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study

  2005cited by this paper
• Microglial activation and dopamine terminal loss in early Parkinson's disease

  2005cited by this paper
• First visualization of adenosine A2A receptors in the human brain by positron emission tomography with [11C]TMSX

  2005cited by this paper
• FDG PET in the differential diagnosis of parkinsonian disorders

  2005cited by this paper
• Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine.

  2004cited by this paper
• PET imaging of amyloid in Alzheimer's disease.

  2004cited by this paper
• Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration

  2004cited by this paper
• Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy

  2004cited by this paper
• An increase of sigma receptors in the aged monkey brain.

  2003cited by this paper
• Adenosine A(2A) receptor antagonist treatment of Parkinson's disease.

  2003cited by this paper
• Adenosine–dopamine interactions

  2003cited by this paper
• Age-related changes of the binding of [3H]SA4503 to sigma1 receptors in the rat brain

  2003cited by this paper
• Age-related changes of the binding of [ 3 H ] SA 4503 to sigma 1 receptors in the rat brain

  2003cited by this paper
• [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy

  2003cited by this paper
• Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX

  2003cited by this paper
• Adenosine A2A receptor antagonist treatment of Parkinson’s disease

  2003cited by this paper
• PET imaging of adenosine A(1) receptors with (11)C-MPDX as an indicator of severe cerebral ischemic insult.

  2003cited by this paper
• Increased regional cerebral blood flow but normal distribution of GABAA receptor in the visual cortex of subjects with early-onset blindness

  2003cited by this paper
• Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET

  2002cited by this paper
• Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography

  2002cited by this paper
• Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease.

  2002cited by this paper
• Assessment of adenosine A2A receptors with PET as a new diagnostic tool for neurological disorders

  2002cited by this paper
• Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: Comparison with the dopamine receptor imaging

  2002cited by this paper
• Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists.

  2002cited by this paper
• New Aspects of Physiological and Pathophysiological Functions of Adenosine A2A Receptor in Basal Ganglia

  2001cited by this paper
• Auditory Triggered Mental Imagery of Shape Involves Visual Association Areas in Early Blind Humans

  2001cited by this paper
• Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

  2001cited by this paper
• Mapping of CNS sigma1 receptors in the conscious monkey: Preliminary PET study with [11C]SA4503

  2001cited by this paper
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

  2001cited by this paper
• In-vivo measurement of activated microglia in dementia.

  2001cited by this paper
• Adenosine in the central nervous system: release mechanisms and extracellular concentrations

  2001cited by this paper
• Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.

  2000cited by this paper
• Intrasubject correlation between static sean and distribution volume images for [11C]flumazenil PET

  2000cited by this paper
• In vivo evaluation of [(11)C]SA4503 as a PET ligand for mapping CNS sigma(1) receptors.

  2000cited by this paper
• 11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.

  2000cited by this paper
• Contribution of PET Studies in Diagnosis of Corticobasal Degeneration

  2000cited by this paper
• In vivo evaluation of [11C]SA4503 as a PET ligand for mapping CNS sigma1 receptors

  2000cited by this paper
• Preserved benzodiazepine receptors in Alzheimer’s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF

  1999cited by this paper
• Cerebellar activation during ataxic gait in olivopontocerebellar atrophy: a PET study

  1999cited by this paper
• Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia

  1999cited by this paper
• Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.

  1999cited by this paper
• Verb generation in Japanese--A multicenter PET activation study.

  1999cited by this paper
• Evolution of neuronal changes in the course of Alzheimer's disease.

  1998cited by this paper
• Evidence for striatal dopamine release during a video game

  1998cited by this paper
• Hereditary spastic paraplegia with a thin corpus callosum and thalamic involvement in Japan

  1998cited by this paper
• Bilateral Representation of Language Function

  1998cited by this paper
• Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites.

  1998cited by this paper
• Bilateral representation of language function. Agenesis of corpus callosum by Wada and PET activation.

  1998cited by this paper
• Influence of ANOVA design and anatomical standardization on statistical mapping for PET activation.

  1998cited by this paper
• Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study.

  1998cited by this paper
• Temporal changes in glial fibrillary acidic protein messenger RNA and [3H]PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat.

  1997cited by this paper
• Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia.

  1997cited by this paper
• Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

  1997cited by this paper
• Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy.

  1997cited by this paper
• Three-dimensional imaging of cortical structure, function and glioma for tumor resection.

  1997cited by this paper
• σ1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test

  1996cited by this paper
• Metabolic coupling between glia and neurons

  1996cited by this paper
• Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test.

  1996cited by this paper
• Role of the nondominant hemisphere and undamaged area during word repetition in poststroke aphasics. A PET activation study.

  1996cited by this paper
• Positron emission tomographic studies of cerebral benzodiazepine‐receptor binding in chronic alcoholics

  1996cited by this paper
• Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes.

  1996cited by this paper
• Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

  1996cited by this paper
• PET examination of the monoamine transporter with [11c]β‐CIT and [11c]β‐CFT in early parkinson's disease

  1995cited by this paper
• Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.

  1995cited by this paper

• The Role of Advanced Imaging in Neurosurgical Diagnosis

  2023cites this paper
• The role of dopamine and serotonin in cervical dystonia

  2018cites this paper
• Orbital pseudotumor and pituitary lesion with cavernous plexus and internal carotid artery deviation : clinical , MRI and ( 18 F )-FDG PET findings

  2015cites this paper
• (18F)-FDG PET/CT AND MRI IN DIAGNOSIS OF IDIOPATHIC LATE-ONSET CEREBELLAR ATAXIA

  2015cites this paper
• Positron Emission Tomography in Autoimmune Disorders of the Central Nervous System

  2015cites this paper
• PET and SPECT Imaging in Dystonia

  2014cites this paper
• Positron Emission Tomography Radiosynthesis in Microreactors

  2012cites this paper
• Structural, functional and molecular imaging of the brain in primary focal dystonia - A review

  2011cites this paper
• Striatal Distribution of Dopamine Transporters and Dopamine D2 Receptors at Different Stages of Parkinson's Disease

  2011cites this paper
• Flow optimization study of a batch microfluidics PET tracer synthesizing device

  2010cites this paper
• Design and Optimization of Coin-Shaped Microreactor Chips for PET Radiopharmaceutical Synthesis

  2010cites this paper
• Development of PET radiopharmaceuticals and their clinical applications at the Positron Medical Center

  2010cites this paper
• Microreactors for radiopharmaceutical synthesis.

  2009cites this paper